Open Surgery for Gastric Cancer: Total Gastrectomy with D2 Lymph Node Dissection

  • Yoon Young Choi
  • Sung Hoon NohEmail author


Total gastrectomy (TG), a total resection of the whole stomach including the cardia and pylorus, is a surgical procedure to treat gastric cancer which is located in proximal stomach and in a case that a satisfactory proximal resection safety margin cannot be guaranteed by distal gastrectomy. As like distal gastrectomy, the extent of lymph node (LN) dissection of TG for advanced gastric cancer is recommended in D2 level, and D2 level for TG additionally includes #2 (left paracardial LNs including those along the esophagocardiac branch of the left subphrenic artery), #4sa (left greater curvature LNs along the short gastric arteries), #10 (splenic hilar LNs including LNs in splenic artery distal to the pancreatic tail, in the roots of the short gastric arteries, and along the left gastroepiploic artery proximal to its first gastric branch), and #11d (distal splenic artery LNs from halfway between its origin and the pancreatic tail end, usually from the beginning of posterior gastric artery from splenic artery, to the end of the pancreatic tail) LN groups along with those of distal gastrectomy. TG for gastric cancer is one of challenging surgical procedure because the extent of TG is wider than that of distal gastrectomy, LN dissection around spleen hilum is technically difficult, and surgical complications such as leak from esophagojejunostomy and pseudoaneurysm at splenic artery could be lethal. In addition, combined resection versus preservation of adjacent organs such as the pancreas and spleen for TG has long been in a debate. In this chapter, we will discuss about the historical changes of surgery for TG and technical aspects for TG with LN dissection. Detailed technique for reconstruction after open TG will be addressed in another chapter.

Supplementary material

(WMV 455750 kb)


  1. 1.
    Schlatter C. Vollstandiger Entfernung des Magens, Oesophagoenterostomie, beim Menschen. Beitr Klin Chir. 1897;19:757.Google Scholar
  2. 2.
    Roux C. L’esophago-jejune-gastrome. Nouvelle Operation Pour Retricissement Infranchissable de L’esophage. Semaine Med. 1907;27:37.Google Scholar
  3. 3.
    Orr TG. A modified technique for total gastrectomy. Arch Surg. 1947;54(3):279–86.CrossRefGoogle Scholar
  4. 4.
    D. G. Zur Technik der Lymphagefass-injection, Eine neue Injectionsmasse fur Lymphagefasse. Polychrome Injection. Anat Anz. 1896;12:216–23.Google Scholar
  5. 5.
    T. K. Lymph node metastasis of gastric cancer. Jpn J Surg. 1944:15–6.Google Scholar
  6. 6.
    Cancer JRSfG. Japanese rules for gastric cancer study. 1st ed. (in Japanese). Tokyo/Osaka/Kyoto: Kanehara & Co LTD; 1962.Google Scholar
  7. 7.
    Cancer JRSfG. Annual report of nationwide registry of gastric cancer patients (in Japanese). Tokyo: National Cancer Center Press; 1972–1998. pp. 154.Google Scholar
  8. 8.
    Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19.CrossRefGoogle Scholar
  9. 9.
    Ajani JA, Bentrem DJ, Besh S, D’Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H, National Comprehensive Cancer Network. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2013;11(5):531–46.CrossRefGoogle Scholar
  10. 10.
    Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, European Society for Medical Oncology, European Society of Surgical Oncology, European Society of Radiotherapy and Oncology. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):vi57–63.PubMedGoogle Scholar
  11. 11.
    Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, Otsuji E. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer. 2011;14(2):172–7.CrossRefGoogle Scholar
  12. 12.
    Sasada S, Ninomiya M, Nishizaki M, Harano M, Ojima Y, Matsukawa H, Aoki H, Shiozaki S, Ohno S, Takakura N. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer. Anticancer Res. 2009;29(8):3347–51.PubMedGoogle Scholar
  13. 13.
    Monig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schroder W, Thiele J, Dienes HP, Holscher AH. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilum. J Surg Oncol. 2001;76(2):89–92.CrossRefGoogle Scholar
  14. 14.
    Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg. 1995;19(4):532–6.CrossRefGoogle Scholar
  15. 15.
    Choi YY, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH. Current practice of gastric cancer treatment. Chin Med J. 2014;127(3):547–53.PubMedGoogle Scholar
  16. 16.
    Choi YY, Noh SH, Cheong JH. Evolution of gastric cancer treatment: from the golden age of surgery to an era of precision medicine. Yonsei Med J. 2015;56(5):1177–85.CrossRefGoogle Scholar
  17. 17.
    Oh SJ, Hyung WJ, Li C, Song J, Kang W, Rha SY, Chung HC, Choi SH, Noh SH. Yonsei gastric cancer C. the effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer. J Surg Oncol. 2009;99(5):275–80.CrossRefGoogle Scholar
  18. 18.
    Lee KY, Noh SH, Hyung WJ, Lee JH, Lah KH, Choi SH, Min JS. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol. 2001;8(5):402–6.CrossRefGoogle Scholar
  19. 19.
    Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg. 2006;93(5):559–63.CrossRefGoogle Scholar
  20. 20.
    Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, Nashimoto A, Ito S, Kaji M, Imamura H, Fukushima N, Fujitani K, Stomach Cancer Study Group of the Japan Clinical Oncology Group. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg. 2017;265(2):277–83.CrossRefGoogle Scholar
  21. 21.
    Bartlett EK, Roses RE, Kelz RR, Drebin JA, Fraker DL, Karakousis GC. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. Surgery. 2014;156(2):298–304.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Surgery, Yonsei University Health SystemYonsei University College of MedicineSeoulRepublic of Korea
  2. 2.Brain Korea 21 PLUS Project for Medical Science, Yonsei University Health SystemYonsei University College of MedicineSeoulRepublic of Korea

Personalised recommendations